We maintain our Neutral recommendation for Greatbatch Inc. (NYSE:GB). Revenues and earnings for first-quarter fiscal 2011 topped the Zacks Consensus Estimates, buoyed by solid double-digit growth across the company’s Vascular Access, Orthopedic and Electrochem franchises. The company’s Vascular business (sales climbed 28% in the quarter) is benefiting from higher introducer sales and favorable ordering trends [...]